Institute of Infectious Diseases, Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.
People's Hospital of Zhuji, Zhejiang Province, Zhuji, China.
Int J Infect Dis. 2018 May;70:1-9. doi: 10.1016/j.ijid.2018.01.007. Epub 2018 Feb 2.
The serological antibody detection tests offer several advantages for the rapid diagnosis of tuberculosis (TB). The Mycobacterium tuberculosis-specific antibody responses associated with different stages of TB infection remain to be investigated.
The Pathozyme-Myco IgG (Myco G), Pathozyme TB Complex Plus (TB Complex), IBL M. tuberculosis IgG ELISA (IBL), Anda Biologicals TB IgG (Anda-TB), and T-SPOT.TB (T-SPOT) tests were performed for 133 active TB patients (ATB group), 131 controls (CON group), and 95 subjects with latent TB infection (LTBI group).
The four serological tests all showed relatively low sensitivity in the ATB group but high specificity in the LTBI and CON groups. The antibody levels of the four serological tests were significantly higher in the ATB group than in the LTBI group. The same trend was observed between the LTBI and CON groups. The four serological tests demonstrated potential diagnostic value in discriminating ATB from LTBI. A combination of the Anda-TB and TB Complex tests exhibited the best diagnostic potential in discriminating ATB from LTBI, with a sensitivity of 89.4% and a specificity of 94.7%. Further, the diagnostic value of Anda-TB and TB Complex were validated in a prospective cohort including 106 patients with suspected ATB. Combined with the T-SPOT test, the tests showed a sensitivity of 87.2% and a specificity of 92.5% for discriminating ATB patients from all ATB suspected cases in the validation group.
The antibody responses of the serological tests all showed significant differences between the ATB and LTBI groups. A combination of Anda-TB and the TB Complex test demonstrated high diagnostic potential in discriminating ATB from LTBI and may be an additional diagnostic tool in the diagnosis of M. tuberculosis infection.
血清抗体检测试验为结核病(TB)的快速诊断提供了多种优势。与 TB 感染不同阶段相关的结核分枝杆菌特异性抗体反应仍有待研究。
对 133 例活动性结核病患者(ATB 组)、131 例对照者(CON 组)和 95 例潜伏性结核感染患者(LTBI 组)进行了 Pathozyme-Myco IgG(Myco G)、Pathozyme TB 复合检测 Plus(TB Complex)、IBL 结核分枝杆菌 IgG ELISA(IBL)、Anda 生物制品 TB IgG(Anda-TB)和 T-SPOT.TB(T-SPOT)检测。
四项血清学检测在 ATB 组中的敏感性均较低,但在 LTBI 和 CON 组中的特异性均较高。四项血清学检测在 ATB 组中的抗体水平均显著高于 LTBI 组。LTBI 组与 CON 组之间也存在相同的趋势。四项血清学检测在区分 ATB 与 LTBI 方面具有潜在的诊断价值。Anda-TB 和 TB Complex 联合检测在区分 ATB 与 LTBI 方面显示出最佳的诊断潜力,敏感性为 89.4%,特异性为 94.7%。此外,在包括 106 例疑似 ATB 患者的前瞻性队列中验证了 Anda-TB 和 TB Complex 的诊断价值。与 T-SPOT 联合检测,在验证组中,该检测对区分 ATB 患者与所有疑似 ATB 患者的敏感性为 87.2%,特异性为 92.5%。
血清学检测的抗体反应在 ATB 组与 LTBI 组之间均存在显著差异。Anda-TB 和 TB Complex 联合检测在区分 ATB 与 LTBI 方面具有较高的诊断潜力,可能是结核分枝杆菌感染诊断的一种附加诊断工具。